124 related articles for article (PubMed ID: 11273010)
1. Increased vigabatrin entry into the brain by polysorbate 80 and sodium caprate.
Dimitrijevic D; Whitton PS; Domin M; Welham K; Florence AT
J Pharm Pharmacol; 2001 Feb; 53(2):149-54. PubMed ID: 11273010
[TBL] [Abstract][Full Text] [Related]
2. Brain GABA editing by localized in vivo (1)H magnetic resonance spectroscopy.
Bielicki G; Chassain C; Renou JP; Farges MC; Vasson MP; Eschalier A; Durif F
NMR Biomed; 2004 Apr; 17(2):60-8. PubMed ID: 15052553
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin extracellular pharmacokinetics and concurrent gamma-aminobutyric acid neurotransmitter effects in rat frontal cortex and hippocampus using microdialysis.
Tong X; Ratnaraj N; Patsalos PN
Epilepsia; 2009 Feb; 50(2):174-83. PubMed ID: 19016829
[TBL] [Abstract][Full Text] [Related]
4. Effects of increasing doses of vigabatrin on platelet gamma-aminobutyric acid-transaminase and brain gamma-aminobutyric acid in rats.
Valdizán EM; García AP; Armijo JA
Eur J Pharmacol; 1999 Mar; 369(2):169-73. PubMed ID: 10206175
[TBL] [Abstract][Full Text] [Related]
5. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.
Sills GJ; Butler E; Forrest G; Ratnaraj N; Patsalos PN; Brodie MJ
Epilepsia; 2003 Jul; 44(7):886-92. PubMed ID: 12823570
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of vigabatrin correlated with whole brain gamma-aminobutyric acid metabolism in audiogenic sensitive rats.
Engelborghs S; Pickut BA; D'Hooge R; Wiechert P; Haegele K; De Deyn PP
Arzneimittelforschung; 1998 Jul; 48(7):713-6. PubMed ID: 9706369
[TBL] [Abstract][Full Text] [Related]
7. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
Valdizán EM; Armijo JA
Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
[TBL] [Abstract][Full Text] [Related]
8. Metabolic precursors and compartmentation of cerebral GABA in vigabatrin-treated rats.
Preece NE; Cerdán S
J Neurochem; 1996 Oct; 67(4):1718-25. PubMed ID: 8858958
[TBL] [Abstract][Full Text] [Related]
9. Monitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting.
Shannon RJ; Timofeev I; Nortje J; Hutchinson PJ; Carpenter KL
Br J Clin Pharmacol; 2014 Nov; 78(5):981-95. PubMed ID: 24802902
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy.
Mattson RH; Petroff OA; Rothman D; Behar K
Acta Neurol Scand Suppl; 1995; 162():27-30. PubMed ID: 7495186
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model.
Löscher W; Jäckel R; Müller F
Eur J Pharmacol; 1989 Apr; 163(1):1-14. PubMed ID: 2744084
[TBL] [Abstract][Full Text] [Related]
12. Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in socially isolated rats.
Sherif F; Oreland L
Behav Brain Res; 1995 Dec; 72(1-2):135-40. PubMed ID: 8788866
[TBL] [Abstract][Full Text] [Related]
13. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.
Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS
Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance detection of increased cortical GABA in vigabatrin-treated rats in vivo.
Preece NE; Jackson GD; Houseman JA; Duncan JS; Williams SR
Epilepsia; 1994; 35(2):431-6. PubMed ID: 8156969
[TBL] [Abstract][Full Text] [Related]
15. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
Petroff OA; Rothman DL; Behar KL; Collins TL; Mattson RH
Neurology; 1996 Dec; 47(6):1567-71. PubMed ID: 8960747
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
Todd KG; Baker GB
J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
[TBL] [Abstract][Full Text] [Related]
17. In vivo monitoring of rat brain metabolites during vigabatrin treatment using localized 2D-COSY.
Welch JW; Bhakoo K; Dixon RM; Styles P; Sibson NR; Blamire AM
NMR Biomed; 2003 Feb; 16(1):47-54. PubMed ID: 12577297
[TBL] [Abstract][Full Text] [Related]
18. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
Petroff OA; Rothman DL
Mol Neurobiol; 1998 Feb; 16(1):97-121. PubMed ID: 9554704
[TBL] [Abstract][Full Text] [Related]
19. Beneficial interaction between vigabatrin and valproate against seizures induced by pentylenetetrazole in mice.
Cuadrado A; Armijo JA
Pharmacol Res; 2005 May; 51(5):489-96. PubMed ID: 15749465
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term vigabatrin therapy on GABA and other amino acid concentrations in the central nervous system--a case study.
Ben-Menachem E; Hamberger A; Mumford J
Epilepsy Res; 1993 Dec; 16(3):241-3. PubMed ID: 8119275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
